Browse by Audience
MEMBER

Update Your Profile
Special Interest Groups (SIG)
Member Spotlights
IASP Connect
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Pain Researcher
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Curricula
Graduate Opportunities
Treatment and Education Resources
Events

PATIENT & CAREGIVER

Resources for Living with Pain
Topic Pages
Free Videos
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner
Make a Donation

I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Combined hormonal contraceptives use among women with contraindications according to the WHO criteria: A systematic review.

< BACK TO ARCHIVE


2020 Dec 27


Sex Reprod Healthc


http://www.ncbi.nlm.nih.gov/pubmed/33545506?dopt=Abstract


27

Combined hormonal contraceptives use among women with contraindications according to the WHO criteria: A systematic review.

Authors

Combined hormonal contraceptives use among women with contraindications according to the WHO criteria: A systematic review.
Houvèssou G M, Farías-Antúnez S, da Silveira M F
Sex Reprod Healthc. 2020 Dec 27; 27:100587.
PMID: 33545506.

Abstract

Combined hormonal contraceptives (CHC), containing estrogen, remain the most popular choice of contraceptive among women. While the method offers many benefits, the use of CHC involves potential health risks. The aim of this study was to analyze the available evidence on the prevalence of CHC use among women with contraindications to their use according to the WHO recommendations (2015).
Read This Paper